enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. GSK to cap out-of-pocket inhaler costs in US - AOL

   www.aol.com/news/gsk-cap-pocket-inhaler-costs...

   The cost cap would apply to all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, including Advair Diskus, Advair HFA, and Trelegy Ellipta, and would apply to patients ...

3. 22-Year-Old With Chronic Asthma Died After Inhaler Price Went ...

   www.aol.com/22-old-chronic-asthma-died-012249667...

   22-Year-Old With Chronic Asthma Died After Inhaler Price Went From $66 to $539: Lawsuit ... Advair Diskus would now cost Schmidtknecht $539.19 out of pocket, and the pharmacy allegedly told him ...

4. Some drugmakers to cap cost of asthma inhalers at $35 a month

   www.aol.com/news/drugmakers-cap-cost-asthma...

   Like insulin, the cost of inhalers in the U.S. is significantly higher than in other wealthy countries. ... or $35 per inhaler. Patients, said Conroy of Ohio State, often require a rescue inhaler ...

5. When the Cost of His Asthma Inhaler Went Up $500, His ... - AOL

   www.aol.com/cost-asthma-inhaler-went-500...

   Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase, but then he died of an asthma attack, per a lawsuit filed by his parents

6. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate/...

   Fluticasone furoate/umeclidinium bromide/vilanterol is only available as an inhaler, which generally contains thirty doses (one-month supply) of medicated powder for inhalation (except in the case of, e.g., sample products from the manufacturer or those produced specifically for hospitals [institutional formulations], which contain 14 doses). [4]

7. Fluticasone/salmeterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone/salmeterol

   In 2012, Advair was part of a larger civil settlement agreement between GlaxoSmithKline (GSK) and the United States, in which GSK agreed to pay $1.043 billion; the United States said that GSK promoted off-label uses of Advair and paid kickbacks to healthcare professionals to sell this drug, among others. [19]